Vera Therapeutics, Inc. (VERA) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Vera Therapeutics, Inc. (VERA) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

VERA Cash Flow Statement

Vera Therapeutics, Inc. (VERA) cash flow statement — 7-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-100.25M	-106.5M	-69.99M	-61.91M	-54.8M	-54.41M	-39.18M	-36.88M	-24.78M	-33.83M	-25.14M	-22.97M	-17.77M	-26.29M	-21.16M	-18.42M	-19.03M	-8.98M	-6.44M	-5.48M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-82.95%	-95.75%	-78.64%	-67.84%	-121.12%	-60.82%	-55.83%	-60.56%	-39.44%	-28.67%	-18.82%	-24.72%	6.63%	-192.75%	-228.7%	-235.89%	-148.31%	-117.93%	76.49%	-
Net Income	-109.47M	-121.03M	-91.1M	-80.29M	-76.53M	-51.69M	-43.42M	-46.63M	-33.71M	-28.38M	-25.66M	-20.1M	-20.16M	-30.07M	-32.44M	-24.68M	-14.85M	-17.09M	-16.85M	-7.61M
Depreciation & Amortization	132K	256K	135K	129K	119K	85K	55K	24K	15K	11K	-635K	6K	517K	-506K	-597K	-152K	-106K	9K	32K	59K
Stock-Based Compensation	15.86M	13.21M	10.96M	9.74M	9.47M	7.74M	6.22M	5.59M	4.87M	4.12M	3.22M	2.92M	2.68M	2.67M	2.75M	2.45M	2.02M	1.66M	962K	933K
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	364K
Other Non-Cash Items	-332K	14.8M	-359K	-173K	-1.24M	-1.1M	-1.3M	-1.73M	-2.11M	-963K	3.22M	-899K	-924K	580K	590K	4.42M	1.09M	564K	5.12M	-125K
Working Capital Changes	-6.44M	-13.73M	10.36M	8.69M	13.38M	-9.44M	-728K	5.86M	6.14M	-8.62M	-2.08M	-4.9M	115K	1.04M	8.54M	-465K	-7.19M	5.87M	4.29M	896K
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	664K	-7.97M	3.63M	4.79M	3.9M	1.6M	3.06M	-62K	-545K	-5.91M	-1.18M	-980K	7.95M	-6.67M	4.98M	-72K	-244K	5.94M	420K	-759K
Cash from Investing	32.86M	-137.82M	80.66M	69.76M	28.54M	15.32M	-221.38M	38.32M	-22.68M	-219.29M	18.56M	16.23M	-86.45M	12.23M	13.44M	-2.44M	-42.09M	-39.45M	-5M	0
Capital Expenditures	0	-173K	-102K	-133K	-208K	-187K	-645K	-25.11M	-89K	0	-63K	0	0	0	0	-38K	-6K	-18K	0	0
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.4K	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	-114K	-15M	0	0	-50K	-750K	0	24.87M	0	0	0	0	0	12.23K	0	-2.4K	0	-39.44K	-5M	0
Cash from Financing	1.92M	3.94M	286.28M	797K	20.29M	1.53M	325.95M	739K	3.44M	276.54M	24.83M	297K	432K	107.98M	20.71M	908K	48K	80.27M	4.92M	0
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	24.74M	0	0	0	0	0	0	0	4.92M	0
Equity Issued (Net)	1.92M	3.94M	304.69M	797K	464K	1.53M	345M	-13K	3.44M	287.54M	87K	0	0	115M	-1K	1K	1K	86.13M	0	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	-13K	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	0	0	-18.41M	0	19.82M	0	-19.05M	752K	3.44M	-11M	24.83M	297K	432K	-7.02M	20.71M	907K	47K	-5.86M	0	0
Net Change in Cash	-65.47M	-240.37M	296.95M	8.65M	-5.97M	-37.56M	65.39M	2.17M	-44.02M	23.42M	18.24M	-6.45M	-103.79M	93.93M	12.98M	-19.95M	-61.08M	31.83M	-6.52M	-5.48M
Free Cash Flow	-100.25M	-106.67M	-70.1M	-62.04M	-55.01M	-54.59M	-39.83M	-61.99M	-24.87M	-33.83M	-25.21M	-22.97M	-17.77M	-26.29M	-21.16M	-18.46M	-19.04M	-9M	-6.44M	-5.48M
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-82.26%	-95.4%	-76%	-0.07%	-121.17%	-61.37%	-58%	-169.86%	-39.94%	-28.67%	-19.11%	-24.46%	6.65%	-192.17%	-228.7%	-236.58%	-148.39%	-118.37%	76.49%	-
FCF per Share	-1.40	-1.49	-1.09	-0.97	-0.86	-0.86	-0.73	-1.13	-0.45	-0.66	-0.57	-0.52	-0.40	-0.70	-0.76	-0.68	-0.70	-0.37	-0.30	-0.26
FCF Conversion (FCF/Net Income)	0.92x	0.88x	0.77x	0.77x	0.72x	1.05x	0.90x	0.79x	0.74x	1.19x	0.98x	1.14x	0.88x	0.87x	0.65x	0.75x	1.28x	0.53x	0.38x	0.72x
Interest Paid	1.65M	0	0	1.77M	0	1.58M	1.66M	0	1.73M	1.52M	0	863K	-1.62M	0	559K	0	113K	0	17K	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0